Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

LianBio to Shut Down Operations; Will Distribute $528 Million to Shareholders

publication date: Feb 14, 2024

LianBio, a Princeton-Shanghai biotech, has decided to call it quits. The company said its best option for the future is to close all its operations. Founded four years ago, LianBio emerged from Perceptive Advisors, a New York City company that invested in biopharmas and has $9.5 billion in assets under management. Perceptive, which wanted to participate in China’s drug development scene, formed LianBio to in-license drugs, mainly from its portfolio companies, and bring them to China/Asia. LianBio plans to stop all its operations by the end of 2024 and will distribute a $4.80 dividend/share ($528 million) to its shareholders. More details....

Stock Symbol: (NSDQ: LIAN)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here